The predictive value of body mass index on prognosis and adverse events of cancers treated with immunotherapy: a systematic review and meta-analysis (Jan, 10.1007/s00262-021-02858-y, 2021)

You Yafei; Jiang Chang; Peng Kunwei; He Wenzhuo; Wang Lei; Jin Yanan; Xia Liangping

首页> 外文期刊>Cancer immunology, immunotherapy : >The predictive value of body mass index on prognosis and adverse events of cancers treated with immunotherapy: a systematic review and meta-analysis (Jan, 10.1007/s00262-021-02858-y, 2021)

【24h】

The predictive value of body mass index on prognosis and adverse events of cancers treated with immunotherapy: a systematic review and meta-analysis (Jan, 10.1007/s00262-021-02858-y, 2021)

机译：免疫疗法治疗预后和不良事件体重指数的预测价值：系统审查与荟萃分析（1月10.1007 / S00262-021-02858-Y，2021）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

A correction to this paper has been published: https://doi.org/10.1007/s00262-021-02907-6

机译：对这篇论文的更正已经发表：https://doi.org/10.1007/s00262-021-02907-6

著录项

来源
《Cancer immunology, immunotherapy :》 |2021年第8期|共1页
作者
You Yafei; Jiang Chang; Peng Kunwei; He Wenzhuo; Wang Lei; Jin Yanan; Xia Liangping;
展开▼
作者单位

Sun Yat Sen Univ Collaborat Innovat Ctr Canc Med State Key Lab Oncol South China Canc Ctr 651;

Sun Yat Sen Univ Collaborat Innovat Ctr Canc Med State Key Lab Oncol South China Canc Ctr 651;

Sun Yat Sen Univ Collaborat Innovat Ctr Canc Med State Key Lab Oncol South China Canc Ctr 651;

Sun Yat Sen Univ Collaborat Innovat Ctr Canc Med State Key Lab Oncol South China Canc Ctr 651;

Sun Yat Sen Univ Collaborat Innovat Ctr Canc Med State Key Lab Oncol South China Canc Ctr 651;

Sun Yat Sen Univ Collaborat Innovat Ctr Canc Med State Key Lab Oncol South China Canc Ctr 651;

Sun Yat Sen Univ Collaborat Innovat Ctr Canc Med State Key Lab Oncol South China Canc Ctr 651;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Value of Preoperative Neutrophil-to-Lymphocyte Ratio in Predicting Prognosis of Surgically Resectable Urinary Cancers: Systematic Review and Meta-Analysis [J] . Zhan Wang, Xu Wang, Wenda Wang, 中国医学科学杂志（英文版） . 2020,第003期
2. Impact of a Low Preoperative Body Mass Index on the Postoperative Complications and Overall Survival of Gastric Cancer Patients: a Systematic Review and Meta-analysis [J] . Huan Wang, Chen Yu Mao, Jing Deng, 肿瘤营养学杂志(英文) . 2019,第004期
3. Impact of a Low Preoperative Body Mass Index on the Postoperative Complications and Overall Survival of Gastric Cancer Patients: a Systematic Review and Meta-analysis [J] . Huan Wang, Chen Yu Mao, Jing Deng, 肿瘤营养学杂志（英文） . 2019,第004期
4. The predictive value of body mass index on prognosis and adverse events of cancers treated with immunotherapy: a systematic review and meta-analysis [J] . You Yafei, Jiang Chang, Peng Kunwei, Cancer immunology, immunotherapy : . 2021,第8期

机译：免疫疗法治疗预后和不良事件体重指数的预测价值：系统评价与荟萃分析
5. Impact of body mass index on survival and serious adverse events in advanced non-small cell lung cancer treated with bevacizumab: a meta-analysis of randomized clinical trials [J] . Shukla Soham, Babcock Zachary, Pizzi Laura, Current medical research and opinion . 2021,第5期

机译：用Bevacizumab处理的高级非小细胞肺癌生存和严重不良事件对体重指数的影响：随机临床试验的META分析
6. Incidence of dermatologic adverse events in patients with cancer treated with concurrent immune checkpoint inhibitors and radiation therapy: A systematic review and meta-analysis [J] . Yan Bernice Y., Wasilewski Gloria, Lacouture Mario E., Journal of the American Academy of Dermatology . 2021,第3期

机译：用同时免疫检查点抑制剂和放射治疗治疗癌症患者皮肤病学不良事件的发病率：系统审查和荟萃分析
7. ADVERSE EVENT REPORTING IN COMPANION ANIMAL CLINICAL TRIALS EVALUATING CANCER THERAPY: A SYSTEMATIC REVIEW [C] . Michelle Giuffrida Conference of the American^College^of^Veterinary^Internal^Medicine . 2016

机译：伴侣动物临床试验评估癌症治疗的不良事件报告：系统审查
8. Predictive Biomarkers of the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treating Advanced Non-small Cell Lung Cancer: A Systematic Review of Randomized Controlled Trials [D] . Yang, Zuyao. 2014

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物：随机对照试验的系统评价。
9. The association between immune-related adverse events and the prognosis of solid cancer patients treated with immunotherapy: a systematic review and meta-analysis [O] . Huilin Xu, Ximing Xu, Wei Ge, 2020

机译：免疫相关不良事件与免疫治疗治疗的固体癌症患者的关联：系统评价和荟萃分析
10. PCN30 INCIDENCE OF ADVERSE EVENTS AMONG CANCER PATIENTS TREATED WITH NIVOLUMAB WITH IPILIMUMAB VERSUS NIVOLUMAB MONOTHERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS [O] . A. Vyas, E.J. Patry, C. Albatal, 2019

机译：PCN30癌症患者对患者的不良事件发生率，与IPILIMIMAB与Nivolumab单药治疗：系统审查和荟萃分析

The predictive value of body mass index on prognosis and adverse events of cancers treated with immunotherapy: a systematic review and meta-analysis (Jan, 10.1007/s00262-021-02858-y, 2021)

摘要

著录项

相似文献

相关主题

期刊订阅